...
首页> 外文期刊>BMC Pulmonary Medicine >Patent foramen ovale revealed by COVID-19 pneumonia
【24h】

Patent foramen ovale revealed by COVID-19 pneumonia

机译:Covid-19肺炎露出的专利植物卵巢

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Platypnea-orthodeoxia syndrome (POS) is a rare condition characterized by dyspnoea (platypnea) and arterial desaturation in the upright position resolved in the supine position (orthodeoxia). Intracardiac shunt, pulmonary ventilation–perfusion mismatch and others intrapulmonary abnormalities are involved. We report a case of POS associated with two pathophysiological issues: one, cardiac POS caused by a patent foramen ovale (PFO) and second, pulmonary POS due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interstitial pneumonia. POS has resolved after recovery of coronavirus disease 2019 (COVID-19) pneumonia. Right-to-left interatrial shunt and intrapulmonary shunt caused by SARS-CoV-2 pneumonia contributed to refractory hypoxemia and POS. Therefore, in case of COVID-19 patient with unexplained POS, the existence of PFO must be investigated.
机译:蛋白质蛋白质氧化氧综合征(POS)是一种罕见的病症,其特征在于呼吸困难(鸭嘴蛋白酶)和在仰卧位(矫形氧ia)中的直立位置中的动脉去饱和。 涉及心内分流,肺通气灌注失配和其他血管内异常。 我们报告了与两种病理生理问题相关的POS的情况:一种,由于严重的急性呼吸综合征冠状病毒2(SARS-COV-2)间质肺炎,由专利吐露卵子(PFO)和第二种,肺部POS引起的心脏POS。 POS已经解决了2019年冠状病毒疾病(Covid-19)肺炎的肺炎。 由SARS-COV-2肺炎引起的左右左侧间隙分流和脑室分流促成难治性低氧血症和POS。 因此,在Covid-19患者具有无法解释的POS的情况下,必须研究PFO的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号